P-glycoprotein and vacuolar ATPase synergistically confer anthracycline resistance to fission yeast and human cells

Current Medicinal Chemistry

Volumn 21, Issue 2, 2014, Pages 251-260

  Tay, Zoey ^a,b   Koo, Seok Hwee ^a,b   Nguyen, Thi Thuy Trang ^a,b   Tan, Tsu Soo ^d   Chen, Ming Li ^a,b   Chin, Chee Fei ^a   Lim, Kim Kiat ^a,b   Ang, Wee Han ^a   Bay, Boon Huat ^a,b   Lee, Edmund J D ^a,b   Chen, Ee Sin ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d SCHOOL OF ENGINEERING   (Singapore)

Author keywords

Doxorubicin; Drug resistance; Fission yeast; P glycoprotein; Vacuolar ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTHRACYCLINE; CARRIER PROTEIN; CONCANAMYCIN A; CORE PROTEIN; CYCLOSPORIN A; DNA BINDING PROTEIN; DOXORUBICIN; EPIRUBICIN; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; PROTEIN COR1; PROTEIN PMD1; PROTEIN RAV1; UNCLASSIFIED DRUG; VACUOLAR ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG RESPONSE; DRUG SENSITIZATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; NONHUMAN; PH; PROTEIN PROTEIN INTERACTION; SCHIZOSACCHAROMYCES; YEAST CELL; ANTAGONISTS AND INHIBITORS; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; ENZYMOLOGY; FEMALE; METABOLISM; PATHOLOGY; UTERINE CERVIX TUMOR;

ADENOSINE TRIPHOSPHATASES; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; DRUG RESISTANCE; FEMALE; HUMANS; P-GLYCOPROTEIN; SCHIZOSACCHAROMYCES; UTERINE CERVICAL NEOPLASMS;

EID: 84893247570     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113206660269     Document Type: Article

References (30)

1. Carvalho, C.; Santos, R.X.; Cardoso, S.; Correia, S.; Oliveira, P.J.; Santos, M.S.; Moreira, P.I. Doxorubicin: The good, the bad and the ugly effect. Curr. Med. Chem., 2009, 16(25), 3267-3285.
2. Pommier, Y.; Leo, E.; Zhang, H.; Marchand, C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem. Biol., 2010, 17(5), 421-433.
3. Mansilla, S.; Llovera, L.; Portugal, J. Chemotherapeutic targeting of cell death pathways. Anticancer Agents Med. Chem., 2012, 12(3), 226-238.
4. Huang, Y.; Sadée, W. Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells. Cancer Lett., 2006, 239(2), 168-182.
5. DeGorter, M.K.; Xia, C.Q.; Yang, J.J.; & Kim, R.B. Drug transporters in drug efficacy and toxicity. Annu. Rev. Pharmacol. Toxicol., 2012, 52, 249-273.
6. Szakács, G.; Paterson, J.K.; Ludwig, J.A.; Booth-Genthe, C.; Gottesman, M.M Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov., 2006, 5(3), 219-234.
7. De Milito, A.; Fais, S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol., 2005, 1(6),779-786.
8. Ueda, K.; Shimabuku, A.M.; Konishi, H.; Fujii, Y.; Takebe, S.; Nishi, K.; Yoshida, M.; Beppu, T.; Komano, T. Functional expression of human P-glycoprotein in Schizosaccharomyces pombe. FEBS Lett., 1993, 330(3), 279-282.
9. Tay, Z.; Eng, R.J.; Sajiki, K.; Lim, K.K.; Tang, M.Y.; Yanagida, M.; Chen, E.S. Cellular robustness conferred by genetic crosstalk underlies resistance against chemotherapeutic drug doxorubicin in fission yeast. PLoS ONE, 2013, 8(1), e55041.
10. Toone, W.M.; Kuge, S.; Samuels, M.; Morgan, B.A.; Toda, T.; Jones, N. Regulation of the fission yeast transcription factor Pap1 by oxidative stress: requirement for the nuclear export factor Crm1 (Exportin) and the stress-activated MAP kinase Sty1/Spc1. Genes Dev., 1998, 12(10), 1453-1463.
11. Nishi, K.; Yoshida, M.; Nishimura, M.; Nishikawa, M.; Nishiyama, M.; Horinouchi, S.; Beppu, T. A leptomycin B resistance gene of Schizosaccharomyces pombe encodes a protein similar to the mammalian P-glycoproteins. Mol. Microbiol., 1992, 6(6), 761-769.
12. Arita, Y.; Nishimura, S.; Matsuyama, A.; Yashiroda, Y.; Usui, T.; Boone, C.; Yoshida, M. Microarray-based target identification using drug hypersensitive fission yeast expressing ORFeome. Mol. Biosyst., 2011, 7(5), 1463-1472.
13. Alfa, C.; Fantes, P.; Hyams, J.; McLeod, M.; Warbrick, E. Experiments with fission yeast - A laboratory course manual, Cold Spring Harbor Laboratory Press: New York, 1993.
14. Dawson, K.; Toone, W.M.; Jones, N.; Wilkinson, C.R. Loss of regulators of vacuolar ATPase function and ceramide synthesis results in multidrug sensitivity in Schizosaccharomyces pombe. Eukaryot. Cell, 2008, 7(6), 926-937.
15. Thornton, G.; Wilkinson, C.R.; Toone, W.M.; Jones, N. A novel pathway determining multidrug sensitivity in Schizosaccharomyces pombe. Genes Cells, 2005, 10(10), 941-951.
16. Wise J.G. Catalytic transitions in the human MDR1 P-glycoprotein drug binding sites. Biochemistry, 2012, 51, 5124-5141.
17. De Milito, A.; Marino, ML.; Fais, S. A rationale for the use of proton pump inhibitors as antineoplastic agents. Curr. Pharm. Des., 2012, 18(10), 1395-406.
18. Trédan, O.; Galmarini, C.M.; Patel, K.; Tannock, I.F. Drug resistance and the solid tumor microenvironment. J. Natl. Cancer Inst., 2007, 99(19), 1441-1454.
19. Forgac, M. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell. Biol., 2007, 8(11), 917-929.
20. Wang, L.; Kitaichi, K.; Hui, C.S.; Takagi, K.; Takagi, K.; Sakai, M.; Yokogawa, K.; Miyamoto, K.I.; Hasegawa, T. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo. Clin. Exp. Pharmacol. Physiol., 2000, 27(8), 587-593.
21. Huss, M.; Ingenhorst, G.; König, S.; Gassel, M.; Dröse, S.; Zeeck, A.; Altendorf, K.; Wieczorek, H. Concanamycin A, the specific inhibitor of V-ATPases, binds to the V(o) subunit c. J. Biol. Chem., 2002, 277(43), 40544-40548.
22. Castro, C.P.; Piscopo, D.; Nakagawa, T.; Derynck, R. Cornichon regulates transport and secretion of TGFalpha-related proteins in metazoan cells. J. Cell Sci., 2007, 120(14), 2454-2566.
23. Hoshino, H.; Uchida, T.; Otsuki. T.; Kawamoto, S.; Okubo, K.; Takeichi, M.; Chisaka, O. Cornichon-like protein facilitates secretion of HB-EGF and regulates proper development of cranial nerves. Mol. Biol. Cell., 2007, 18(4), 1143-1152.
24. He, C.; Sun, X.P.; Qiao, H.; Jiang, X.; Wang, D.; Jin, X.; Dong, X.; Wang, J.; Jiang, H.; Sun, X. Downregulating hypoxia-inducible factor-2- improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma. Cancer Sci., 2012, 103(3), 528-534.
25. Roguev, A.; Bandyopadhyay, S.; Zofall M.; Zhang, K.; Fischer, T.; Collins, S.R.; Qu, H.; Shales, M.; Park, H.O.; Hayles, J.; Hoe, K.L.; Kim, D.U.; Ideker, T.; Grewal, S.I.; Weissman, J.S.; Krogan, N.J. Conservation and rewiring of functional modules revealed by an epistasis map in fission yeast. Science, 2008, 322(5900), 405-410.
26. Toldo, S.; Goehe, R.W.; Lotrionte, M.; Mezzaroma, E.; Sumner, E.T.; Biondi-Zoccai, G.G.L.; Seropian, I.M.; Van Tassell, B.W.; Loperfido, F.; Palazzoni, G.; Voelkel, N.F.; Abbate, A.; Gewirtz, D.A. Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse. PLoS ONE, 2013, 8(3), e58421.
27. Dang, C.V. Links between metabolism and cancer. Genes Dev., 2012, 26(9), 877-890.
28. Fais, F. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism. J. Intern. Med., 267, 5, 515-525.
29. Ouar, Z.; Bens, M.; Vignes, C.; Paulais, M.; Pringel, C.; Fleury, J.; Cluzeaud, F.; Lacave, R.; Vandewalle, A. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drugresistant renal epithelial cells. Biochem. J., 2003, 370(Pt 1), 185-193.
30. Mellor, H.R.; Callaghan, R. Accumulation and distribution of doxorubicin in tumour spheroids: the influence of acidity and expression of P-glycoprotein. Cancer Chemother. Pharmacol., 2011, 68(5), 1179-1190.